A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
Clinical trial NCT00606268 · COMPLETED
Trial details
- NCT number
- NCT00606268
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.